Related Experiment Video
Updated: Mar 11, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Presenting treatment safety data: subjective interpretations of objective information
Sara W Faulks1, Steven R Feldman1
1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Abstract:
Educating patients about the risks of treatment is obligatory. An inherent problem with risk education is that patients can become terrified of rare risks associated with the treatment, resulting in possible treatment refusal, poor adherence, and continued disease symptoms. Such fears are a common obstacle observed with the use of biologic medications to treat psoriasis. In this article, we use graphical presentation of psoriasis safety data to illustrate how patients subjectively interpret objective information. Different ways of presenting safety data graphically include the use of truncated, full, and inversed y-axes, resulting in certain likely perceptions by the patient. Despite a physician's best intentions to give a patient objective information, patients will subjectively interpret objective safety data. Therefore, when presenting information, whether in the form of numerical descriptions or graphical presentations, the physician must use his/her best judgment to determine how to present safety data to patients to ensure their well-being and properly inform them about their treatment options.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blind Procedures
Bioequivalence Data: Statistical Interpretation
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Hazard Ratio
For example, in a clinical trial...